You know the customer. Comes in every month for the dog's allergy meds, grabs a bag of toppers while they wait, maybe a new chew toy on the way out. The prescription brought them through the door. The rest of the basket paid your rent.
CVS just removed the reason they had to come back.
Antibiotics, flea meds, and insulin at 9,000 counters
CVS Health announced that common prescription medications for dogs and cats are now available at approximately 9,000 CVS Pharmacy locations nationwide. Pet owners can fill scripts for antibiotics, allergy meds, flea and tick control, insulin, and pain relievers at their local CVS, with the same automatic refills and prescription syncing they use for their own meds. Select medications are eligible for delivery. The company says pet owners can present a written prescription or have their veterinarian contact the pharmacy directly, and CVS is adding electronic prescription capabilities in the coming months.
Sid Tenneti, Senior Vice President and Interim President of Pharmacy and Consumer Wellness at CVS Health, said the move lets CVS Pharmacy "serve every member of the family" and positions the chain as "a true one-stop destination for care."
One of the last reasons a customer had to come back
Pet prescriptions were one of the last reasons a customer had to come back to a specialty store instead of ordering online or stopping at a big-box on the way home. CVS just commoditized that tether. The visit loss matters more than the margin loss. A pet parent who fills a script at CVS stops browsing your treat wall, stops impulse-buying that $18 salmon topper, stops noticing the new chew display you built last week.
For independents who bundled Rx fulfillment with loyalty programs or nutrition consults, you now compete against a pharmacy chain with convenient locations, extended hours, and insurance integration. The stores that never offered compounding or niche meds already lost the high-margin Rx business. CVS just commoditized what was left.
The structural threat isn't the script itself. It's the visit frequency. Prescription pickups fed impulse categories, seasonal endcaps, and the kind of unplanned basket adds that keep turn rates healthy. When that monthly touchpoint moves to a drugstore, your traffic model breaks before your margin model does.
The cross-shop trip rate drops now
For the store owner: If you counted on pet parents picking up antibiotics or flea meds to also grab a bag of food or a toy, that cross-shop trip rate drops starting now. The customer who used to come in regularly for refills might come in far less often, and only when they run out of kibble. You need to replace that visit frequency or watch basket size and turn rates sag together.
For the buyer: Traffic from Rx pickups fed impulse categories. Treat walls, seasonal endcaps, the new freeze-dried line you're testing, all of it depended on foot traffic you may have just lost. If scripts drove a meaningful portion of your monthly visits, you need a plan to pull those customers back in for a different reason, or accept that some SKUs that turned well now turn slower.
For the brand/DTC operator: Independents who lose Rx-driven traffic will tighten their assortments and cut SKUs that don't move fast enough to justify the slot. If your product lived on impulse or needed a store associate to explain it, winning shelf space just got tougher. The stores that survive this will stock fewer brands and demand better terms.